For new-onset neutropenia in the hospitalized patient
Trajectory earns escalation. Non-progression earns release.
1. How this module fits in Consult Practice
| Lens | What it contributes here |
|---|---|
| Orientation | Defines what kind of danger is plausible right now |
| Thinking | Specifies which signals should raise or lower concern |
| Execution | Translates those signals into escalation or restraint and clear reassessment triggers |
2. What this module is for
To answer:
What new data would make me increase vigilance, narrow the terrain, or release concern safely?
3. How to use this module
Use this as a reassessment lens.
You are not collecting a checklist.
You are watching for posture-shifting signals that justify:
- escalation,
- continued surveillance, or
- release by non-progression.
4. Why this matters
Most errors in neutropenia are posture errors: reassurance too early, or escalation without trajectory.
This module keeps vigilance aligned to what actually changes risk.
5. Core Content
A. Posture shift table (escalate, maintain, release)
| New information | How it changes posture (Thinking) | What it implies for visible behavior (Execution, without protocols) |
|---|---|---|
| Fever, hypotension, new instability | increases danger weighting immediately, regardless of explanatory story | protective escalation, explicit communication of triggers and urgency |
| ANC continues falling or crosses into deeper reserve loss | increases reserve-threat weighting, widens danger terrain | tighten monitoring cadence, clarify overnight contingency expectations |
| ANC stabilizes then rises over 48–72 hours | supports release-by-non-progression | visible de-escalation and clear narrative of why concern is released |
| Smear or CBC suggests broader pattern (other lines falling) | shifts from isolated to multi-lineage terrain | broaden scope of concern, communicate that terrain has changed |
| Clear temporal relationship to a new medication | increases weight of drug-associated category (still provisional) | communicate hold consideration for non-essential contributors, set expectation of revisability |
| Clinical course remains stable with no new signals | gradually demotes high-risk hypotheses | explicitly state what is being watched less closely and why |
B. “Escalation language” vs “release language” (to prevent drift)
Escalation language (reserve-threat):
“Because immune reserve is shrinking and danger can be hidden, we should treat instability as a posture shift.”
Release language (non-progression):
“We’re releasing earlier high-risk concern because trajectory did not reinforce it, not because we proved a diagnosis false.”
6. Bottom line
Posture shifts in neutropenia are driven by trajectory, not elegance.
Use these signals to revise weight explicitly, and to communicate why escalation or release is correct at that moment in time.